KAUR, M. and MISRA, S. 2025. REMTERNETUG: AN INVESTIGATIONAL MONOCLONAL ANTIBODY AGAINST Β-AMYLOID FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD). International Journal of Current Pharmaceutical Research. 17, 3 (May 2025), 7–9. DOI:https://doi.org/10.22159/ijcpr.2025v17i3.55038.